Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.78 |
| ▸ | PTPRC | P08575 | 2/20 | 0.76 |
| ▸ | CTSL | P07711 | 1/20 | 0.76 |
| ▸ | CTSS | P25774 | 1/20 | 0.76 |
| ▸ | PTPN13 | Q12923 | 1/20 | 0.76 |
| ▸ | TDP2 | O95551 | 3/20 | 0.71 |
| ▸ | NSD2 | O96028 | 3/20 | 0.71 |
| ▸ | PAX8 | Q06710 | 3/20 | 0.71 |
| ▸ | MEN1 | O00255 | 2/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.71 |
| ▸ | ABL1 | P00519 | 1/20 | 0.71 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.71 |
| ▸ | CES1 | P23141 | 1/20 | 0.71 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.71 |
| ▸ | THRB | P10828 | 1/20 | 0.71 |
| ▸ | BLM | P54132 | 1/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.65 |
| ▸ | S100A4 | P26447 | 6/20 | 0.64 |
| ▸ | CDC25B | P30305 | 4/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29746876 | 1.00 | GAA (0.78) | GAAPTPRCCTSLCTSSPTPN13 | |
| SCHEMBL5915065 | 0.93 | TDP2 (0.81) | GAAPTPRCCTSLCTSSPTPN13 | |
| SCHEMBL29566445 | 0.91 | PTPRC (0.88) | GAAPTPRCCTSLCTSSPTPN13 | |
| SCHEMBL30799541 | 0.91 | PTPRC (0.91) | GAAPTPRCCTSLCTSSPTPN13 | |
| SCHEMBL1899280 | 0.91 | PTPRC (0.88) | GAAPTPRCCTSLCTSSPTPN13 | |
| SCHEMBL69772 | 0.91 | PTPRC (0.91) | GAAPTPRCCTSLCTSSPTPN13 | |
| SCHEMBL5915061 | 0.91 | GAA (0.86) | GAAPTPRCCTSLCTSSPTPN13 | |
| Bromide SCHEMBL28836578 | 0.89 | PTPRC (0.84) | GAAPTPRCCTSLCTSSPTPN13 | |
| SCHEMBL9267635 | 0.88 | TDP2 (0.74) | GAAPTPRCCTSLCTSSPTPN13 | |
| SCHEMBL30774319 | 0.88 | GAA (1.00) | GAAPTPRCCTSLCTSSPTPN13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119707809-A | Azaanthraquinone compound, preparation method thereof and application thereof in flow battery | 中国科学院大连化学物理研究所 | 2025-03-28 | — | — | CN | claimed |
| CN-114196973-B | Method for electrochemically synthesizing aza-anthraquinone derivative | 南京工业大学 | 2022-12-09 | — | — | CN | claimed |
| CN-113425725-B | Application of schizophyllum commune and its extract in preparation of anti-helicobacter pylori medicines | 南京中医药大学 | 2022-05-10 | — | — | CN | claimed |
| CN-114196973-A | Method for electrochemically synthesizing aza-anthraquinone derivative | 南京工业大学 | 2022-03-18 | — | — | CN | claimed |
| CN-113425725-A | Application of dehiscent fruit and its extract in preparing medicine for resisting helicobacter pylori | 南京中医药大学 | 2021-09-24 | — | — | CN | claimed |
| CN-113005158-A | Preparation method and application of azaanthraquinone alkaloid | 青海民族大学 | 2021-06-22 | — | — | CN | claimed |
| WO-2020084828-A1 | POLYMER, ELECTRODE ACTIVE SUBSTANCE AND SECONDARY BATTERY | 学校法人早稲田大学 | 2020-04-30 | — | — | WO | claimed |
| EP-1080090-A1 | ANTITUMOUR 1,5-DIAZAANTHRAQUINONES | UNIVERSIDAD COMPLUTENSE DE MADRID (ES) | 2001-03-07 | — | — | EP | claimed |
| WO-1999059996-A1 | ANTITUMOUR 1,5-DIAZAANTHRAQUINONES | UNIVERSIDAD COMPLUTENSE DE MADRID (ES) | 1999-11-25 | — | — | WO | claimed |
| EP-0680481-B1 | DERIVATES OF AZAANTHRAQUINONE AND AZAXANTHONE, HERBICIDES AND PLANT GROWTH REGULATORS CONTAINING THE SAME | BASF AG (DE) | 1998-04-01 | — | — | EP | claimed |
| EP-3753997-B1 | LATENT ADDITIVE AND COMPOSITION CONTAINING LATENT ADDITIVE | ADEKA CORP (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-20260097359-A1 | MULTI-TUBULAR ELECTROCHEMICAL CELL FOR TARGET SPECIES SEPARATIONS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2026-04-09 | — | — | US | disclosed |
| US-12458922-B2 | Electroactive species and method for electrochemical gas separation | VERDOX, INC. (US) | 2025-11-04 | — | — | US | disclosed |
| US-20250312733-A1 | METHOD FOR ELECTROCHEMICAL GAS SEPARATION | VERDOX INC (US) | 2025-10-09 | — | — | US | disclosed |
| US-12364949-B2 | Method for electrochemical gas separation | VERDOX, INC. (US) | 2025-07-22 | — | — | US | disclosed |
| EP-0574195-A1 | Antitumoral aza- and diazaanthracenes | UNIVERSIDAD COMPLUTENSE DE MADRID (ES) | 1993-12-15 | — | — | EP | disclosed |
| WO-1992022297-A1 | NEW COMPOUNDS AND COMPOSITIONS USEFUL AS ANTIFUNGAL AND ANTIMYCOBACTERIAL AGENTS | THE UNIVERSITY OF MISSISSIPPI (US) | 1992-12-23 | — | — | WO | disclosed |
| US-5162320-A | 1,4-BIS(ALKYLAMINO)-2,3-DIAZA-ANTHRACENE-9,10-DIONES | BOEHRINGER BIOCHEMIA ROBIN S.P.A. (IT) | 1992-11-10 | — | — | US | disclosed |
| EP-0497809-A1 | 1,4-BIS(ALKYLAMINO)-2,3-DIAZA-ANTHRACENE-9,10-DIONES. | BOEHRINGER MANNHEIM ITALIA (IT) | 1992-08-12 | — | — | EP | disclosed |
| WO-1991006540-A1 | 1,4-BIS(ALKYLAMINO)-2,3-DIAZA-ANTHRACENE-9,10-DIONES | BOEHRINGER BIOCHEMIA ROBIN S.P.A. (IT) | 1991-05-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260097359-A1 | MULTI-TUBULAR ELECTROCHEMICAL CELL FOR TARGET SPECIES SEPARATIONS | SLC9A2, SLC9A1, SLC9A3 | GAA 4425/4885PTPRC 396/4885CTSL 4648/4885 |
| US-12458922-B2 | Electroactive species and method for electrochemical gas separation | LPO, SQOR, QSOX1 | GAA 1576/4885PTPRC 1914/4885CTSL 3834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.